NuGen Medical Devices Inc (NGMD.V) remains stagnant in price while navigating regulatory challenges and innovation efforts.
This week, NuGen Medical Devices Inc (NGMD.V) has seen no change in stock price, closing at C$0.01. The company continues to face challenges as it works on renewing its Health Canada license while also pushing forward with its R&D initiatives. Here’s a closer look at the current price action and relevant company news.
Advertisement
NuGen Medical Devices Inc
NGMD.V
NGMD.V
NuGen Medical Devices Inc
WealthAwesomeMarket cap
$3.41M
52W high
$0.06
52W low
$0.01
1W change
+0.00%
Beta
1.57
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on NGMD's historical volatility
30-Day Vol
242.4%
Annualized
90-Day Vol
216.3%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.01
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.01 | C$0.01 – C$0.03 |
| 60 trading days | C$0.01 | C$0.00 – C$0.04 |
| 90 trading days | C$0.01 | C$0.00 – C$0.05 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should be aware of NuGen's ongoing efforts to innovate and navigate regulatory hurdles, as these factors could impact future performance and market perception.
NuGen Medical Devices Inc's stock has dropped 57.14% year-to-date.
With a market cap of approximately C$3.41 million and a profit margin of 0.0%, NuGen is navigating financial challenges amid its growth ambitions.
Bull case
NuGen's focus on R&D advancements, like developing a next-generation variable-dose jet injector, could position the company favorably in the health care market if successful. This innovation may enhance patient care and open new revenue streams.
Bear case
The expiration of NuGen's Health Canada license has halted device sales in Canada, posing a significant risk to revenue and growth prospects. This regulatory setback could hinder the company's ability to recover and expand in the market.
Current Price Action
Advertisement
NuGen Medical Devices Inc (NGMD.V) has maintained its price at C$0.01 with no fluctuations over the past week. The stock has experienced a significant decline of 57.14% year-to-date, indicating ongoing challenges in the market.
Company News and Developments
While there has been no recent company news directly affecting the stock price this week, several headlines highlight NuGen's strategic developments. The company has been working on renewing its Health Canada license, which expired earlier this year, leading to a temporary halt in device sales. This is critical as it emphasizes the importance of regulatory compliance for their operations. Additionally, innovations such as a next-generation variable-dose jet injector and a dual spring technology for needle-free injections indicate ongoing R&D efforts aimed at enhancing patient comfort and clinical outcomes.
Technical Picture
From a technical perspective, NuGen’s stock is currently trading below its 50-day moving average (C$0.02) and 200-day moving average (C$0.02), indicating a bearish trend. The stock has a beta of 1.57, suggesting higher volatility compared to the market. With a 52-week range of C$0.01 to C$0.06, it is currently at the bottom of this range. Volume for the latest trading session was 260,000 shares, significantly above the 20-day average volume of 85,189 shares, indicating heightened interest or activity.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
